Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether his Department has reviewed the rate of uptake of biologic medicines for severe asthma relative to the eligible population.

The Department has not conducted any such review, but this information is available via the NHS England Innovation Scorecard, which is published bi-annually.

Across all disease areas, though the 10-Year Health Plan and the Life Sciences Sector Plan, the Government has commitment to reducing friction in the system to optimise access and uptake of new medicines so the most clinically and cost-effective can reach patients faster. These actions will speed up market access for new medicines and reduce local unwarranted variation in medicine use.